Overcoming breast cancer heterogeneity and resistance using a novel therapeutic approach targeting the metastasis suppressor NDRG1. [ 2018 - ]

Research Grant

Researchers: Dr Zaklina Kovacevic (Principal investigator)

Brief description Breast cancer (BrCa) is the leading cause of cancer death in women and current treatments suffer from development of resistance, leading to metastatic progression. I will assess a novel treatment strategy for BrCa, targeting a gene that is able to inhibit multiple key drivers of BrCa, using a novel potent and selective anti-cancer agent. This approach has the potential to overcome resistance to current therapies and alleviate the onset of metastasis, to improve prognosis for BrCa patients.

Funding Amount $431,000.00

Funding Scheme Career Development Fellowships

Notes RD Wright Biomedical CDF